Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease‐modifying therapies

AIMS: To evaluate the immunogenicity and safety of a seasonal influenza vaccine in a cohort of multiple sclerosis (MS) patients receiving different immunomodulating/immunosuppressive therapies and assess predictors of immune response. METHODS: A prospective, multicenter, non‐randomized observational...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :CNS Neurosci Ther
Главные авторы: Metze, Christoph, Winkelmann, Alexander, Loebermann, Micha, Hecker, Michael, Schweiger, Brunhilde, Reisinger, Emil Christian, Zettl, Uwe Klaus
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2018
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6488907/
https://ncbi.nlm.nih.gov/pubmed/30044050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13034
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы